Publicaciones en colaboración con investigadores/as de Stanford University School of Medicine (6)

2014

  1. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma

    Oncotarget, Vol. 5, Núm. 16, pp. 6854-6866

2013

  1. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 30, pp. 12391-12396

2012

  1. CD44+ cells have cancer stem cell-like properties in nasopharyngeal carcinoma

    International Forum of Allergy and Rhinology, Vol. 2, Núm. 6, pp. 465-470

  2. Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy

    PLoS ONE, Vol. 7, Núm. 12

  3. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 17, pp. 6662-6667

2009

  1. Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy

    Molecular Cancer, Vol. 8